Drug Database
Back to search

Switzerland· 68327001

Olmesartan Amlodipin HCT Zentiva

A olmesartan medoxomil, amlodipin und hydrochlorothiazid product, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC C09DX03

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedOlmesartan Amlodipin HCT ZentivaATCC09DX03REGISTER NO.68327001PACKS LISTED1CHECKEDJune 4, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about OlmesartanAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Olmesartan medoxomil, amlodipin und hydrochlorothiazid is registered in 9 of 19 countries.

Countries holding a registration under ATC C09DX03 (olmesartan medoxomil, amlodipin und hydrochlorothiazid), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 7 of them publish a price we can compare per daily dose
Search olmesartan medoxomil, amlodipin und hydrochlorothiazid products by name

Olmesartan medoxomil, amlodipin und hydrochlorothiazid · ATC C09DX03

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Manufacturer
—
Country
Switzerland (CH)
ATC code
C09DX03
ATC class
Olmesartan medoxomil, Amlodipin und Hydrochlorothiazid
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • gtin
    7680683270018
    Blist 28 Stk
    CHF 30.8

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

36 interactions on record for olmesartan medoxomil, amlodipin und hydrochlorothiazid.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check olmesartan medoxomil, amlodipin und hydrochlorothiazid against other medicinesHow interaction checks work

Olmesartan medoxomil, amlodipin und hydrochlorothiazid · interactions on record

36 records

36 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same class

Other records under C09DX03

Olmesartan medoxomil, amlodipin und hydrochlorothiazid, as other registers publish it.

All olmesartan medoxomil, amlodipin und hydrochlorothiazid products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ca6f69ad-dc9f-41fd-80b2-79afc9640704
GET /v1/drugs/ca6f69ad-dc9f-41fd-80b2-79afc9640704?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "olmesartani medoxomilum 20 mg + amlodipinum 5 mg + hydrochlorothiazidum 12.5 mg",
  "valid_from": "2022-05-01",
  "limitations": "[{\"description\":\"Die gleichzeitige Therapie mit Olmesartan Amlodipin HCT Zentiva und einem Calciumantagonisten des I.T. 02.06. und/oder einem Angiotensin-II-Antagonisten und/oder einem ACE-Hemmer wird von der obligatorischen Krankenpflegeversicherung nicht vergütet.\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2025-10-01\"}]",
  "galenic_form": "Filmtabl 20/5/12.5",
  "therapeutic_area": null,
  "sl_inclusion_date": "2022-05-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about olmesartan medoxomil, amlodipin und hydrochlorothiazid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console